← Back to federal legislation
S. 665In committee

Fatal Overdose Reduction Act of 2025

Introduced: Feb 20, 2025

Latest action date: Feb 20, 2025

Latest development

Read twice and referred to the Committee on Finance.

Civixly approval

No ratings yet

0 ratings

Not enough ratings yet. Public approval appears at 5+ ratings.

Your view
0 comments
Congress
119th Congress
Introduced
Feb 20, 2025
Recorded roll calls
0

Status detail: The most advanced recorded stage is committee consideration.

Plain-language overview

What this bill does

Fatal Overdose Reduction Act of 2025

This bill establishes a five-year Medicaid demonstration program to support the provision of comprehensive and accessible services to treat opioid use and substance use disorders.

Specifically, the bill establishes a demonstration program through which states may receive a Federal Medical Assistance Percentage (i.e., federal matching rate) of at least 90% for services provided by organizations that serve as Health Engagement Hubs. States must certify that these organizations provide a certain level of services, including physical and behavioral health services that are easily and quickly accessible, peer support services, and targeted case management. Organizations must also meet specified minimum staffing requirements, have a community advisory board, and be equipped to provide certain social services (e.g., employment counseling).

The Centers for Medicare & Medicaid Services (CMS) may select up to 10 states to participate in the program. The bill provides funds for state planning grants and administration of the program.

The CMS must contract with an entity to evaluate the program, and the Government Accountability Office must report on this evaluation.

Official summary from Congress.gov.

Civixly topics

What this legislation is about

Civixly topics make federal and state legislation comparable. They are derived from the official CRS policy area and legislative subjects.

Official CRS policy area

Health

View 16 official legislative subjects
Congressional oversightData collection, sharing, protectionDrug trafficking and controlled substancesDrug, alcohol, tobacco useEmployee hiringGovernment information and archivesHealth care costs and insuranceHealth care coverage and accessHealth personnelHealth programs administration and fundingHealth promotion and preventive careMedicaidMental healthPrescription drugsPublic contracts and procurementState and local government operations

Committee activity

Committees and subcommittees that received, reviewed, marked up, or reported this legislation.

Amendments

Proposed changes to this measure, with their latest official outcome or action from Congress.gov.

No amendments are listed for this measure.

Checked against Congress.gov Oct 17, 2026.

Action timeline

Newest action first. Action language comes from the official Congress.gov record.

View full action timeline2 actions
  1. Read twice and referred to the Committee on Finance.

    IntroReferralSenate
  2. Introduced in Senate

    IntroReferralLibrary of Congress

Roll-call votes

Recorded House and Senate votes connected to this bill. Your representatives appear first when available.

No connected roll-call votes are currently available for this bill.

Discussion

0 comments across 0 threads

Sign in to join the discussion.Comments are publicly visible.

Loading comments...

Sources: Congress.gov and official House and Senate vote records.

View data freshness details

Base metadata check pending · Civixly summary check pending · Action timeline checked Oct 17, 2026 · Complete sponsorship check pending · Topics checked Oct 17, 2026 · Committees checked Oct 17, 2026 · Status checked Oct 17, 2026 · Related bills checked Oct 17, 2026.